Skip to content
Home/Companies/Healthcare/InBrain Pharma
InBrain Pharma

InBrain Pharma

Healthcare·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns InBrain Pharma?

InBrain Pharma is currently owned by Finovam Gestion through FIRA (2015 vintage), since 2018.

Hand-verified · updated 2026-04-21

Finovam Gestion
Investor
Finovam Gestion
FIRA · 2015 · VC

Key facts

HQFrance
SectorHealthcare
Websiteinbrainpharma.com

More from FIRA

Other portfolio companies in the same fund.

Innobiochips
Innobiochips
Active
HealthcareFrance· 2023
Nolej
Nolej
Active
EdTechFrance· 2023
Apmonia Therapeutics
Apmonia Therapeutics
Active
HealthcareFrance· 2022
Augmenteo
Exited 2023
GamingFrance· 2020
G-Lyte
Active
ClimateTechFrance· 2020
Retail Shake
Retail Shake
Active
Data & AnalyticsFrance· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Inbrain Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Inbrain Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue